Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Bergthora Eiriksdottir"'
Autor:
Astri Maaland, Adam O'Shea, Helen Heyerdahl, Bergthora Eiriksdottir, Jostein Dahle, Arne Kolstad, Veronique Pascal, Jan Terje Andersen
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
Purpose The aim of this study was to explore the β-emitting lutetium-177 labelled anti-CD37 antibody NNV003 (177Lu-NNV003, Humalutin®) for the treatment of non-Hodgkin’s lymphoma in in vitro studies and in animal models. Methods Cytotoxicity of 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::feca79711a0b77cd03ba5e1e8b00dd63
https://doi.org/10.1007/s00259-019-04417-1
https://doi.org/10.1007/s00259-019-04417-1
Autor:
Ada H. V. Repetto-Llamazares, Adam O'Shea, Bergthora Eiriksdottir, Roy H. Larsen, Trond Stokke, Marion Masitsa Malenge, Jostein Dahle
Publikováno v:
European Journal of Haematology. 101:522-531
Objectives To investigate the therapeutic potential of the next-generation anti-CD37 radioimmunoconjugate 177 Lu-lilotomab satetraxetan (177 Lu-lilotomab) in combination with the anti-CD20 antibody rituximab for treatment of mice with non-Hodgkin's l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f2904577a122e2302906a3f0e730d880
https://doi.org/10.1111/ejh.13139
https://doi.org/10.1111/ejh.13139
Autor:
Roy H. Larsen, Roman Generalov, Ada H. V. Repetto-Llamazares, Bergthora Eiriksdottir, Trond Stokke, Landsverk Kirsti, Jostein Dahle
Publikováno v:
Blood. 126:3245-3245
Immunotherapy (IT) with the anti-CD20 monoclonal antibody rituximab in combination with chemotherapy has resulted in significantly improved response rate and survival in patients with various types of CD20 positive B-cell lymphoproliferative disorder
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77a0962c8728f4d0e3f437d29c368a2b
https://doi.org/10.1182/blood.v126.23.3245.3245
https://doi.org/10.1182/blood.v126.23.3245.3245